Abstract has been submitted for the 2024 ARVO congress.
Disclosure: M. Cozzi, Bayer (R), Nidek (R), Novartis (R), Zeiss (R), Heidelberg Engineering (R); M. Casaluci, None; G. Ruggi, None; M. Airaldi, None; F. Romano, None; A. Bertoni, None; M. Green-Gomez, None; J.M. Nolan, Heidelberg Engineering (C), Macuhealth LLC (C), Stauber Nutrition (C), Industrial Orgánica SA de CV C (C); G. Staurenghi, Heidelberg Engineering (C), Optos (F), Ocular Instruments (P), OptoVue (F), CenterVue (C), Allergan (C), Bayer (C), Genetech (C), Novartis (C), Quantel Medical (C), Carl Zeiss Meditec (C), Appellis (C), Boheringer (C), Topcon (F), Roche (C); A. Invernizzi, Bayer (C), Novartis (C), Roche (C), Heidelberg Engineering (R), Allergan (R)